![](/img/cover-not-exists.png)
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO)
Wohl, David A, Orkin, Chloe, Doroana, Manuela, Pilotto, José H, Sungkanuparph, Somnuek, Yeni, Patrick, Vanveggel, Simon, Deckx, Henri, Boven, KatiaVolume:
19
Year:
2014
Language:
english
Journal:
Antiviral Therapy
DOI:
10.3851/IMP2721
File:
PDF, 248 KB
english, 2014